Home › Aplastic Anemia
Pag-aaral pangklinika para sa Aplastic Anemia na nagre-recruit sa U.S.
27 pag-aaral para sa Aplastic Anemia ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Washington, DC8 pag-aaral
- Baldwin Park, CA7 pag-aaral
- New York City, NY5 pag-aaral
- Atlanta, GA5 pag-aaral
- Philadelphia, PA4 pag-aaral
- Milwaukee, WI4 pag-aaral
- St. Louis, MO4 pag-aaral
- Houston, TX4 pag-aaral
- Nashville, TN4 pag-aaral
- Columbus, OH4 pag-aaral
- Seattle, WA4 pag-aaral
- Durham, NC4 pag-aaral
- Memphis, TN3 pag-aaral
- Richmond, VA3 pag-aaral
- Detroit, MI3 pag-aaral
- Birmingham, AL3 pag-aaral
- Mountain View, CA3 pag-aaral
- Baltimore, MD3 pag-aaral
Ayos sa estado
- Alabama3 pag-aaral
- California7 pag-aaral
- Florida5 pag-aaral
- Georgia5 pag-aaral
- Maryland10 pag-aaral
- Michigan3 pag-aaral
- Minnesota3 pag-aaral
- Missouri4 pag-aaral
- New York7 pag-aaral
- North Carolina4 pag-aaral
- Ohio5 pag-aaral
- Pennsylvania5 pag-aaral
- Tennessee6 pag-aaral
- Texas4 pag-aaral
- Virginia4 pag-aaral
- Washington4 pag-aaral
- Wisconsin4 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
Nagre-recruitPhase 1/2
Edad 12 hanggang 120 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT06303193Cancer in Inherited Bone Marrow Failure Syndromes
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
1 Day – 100 Years · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT00027274Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
Nagre-recruitPhase 2
Edad 4 hanggang 80 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT01174108HPC Offered for PRESERVE Expansion
Nagre-recruitObservasyonal na pag-aaral
Edad 12 hanggang 80 · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07145411A Phase 1/2 Study to Evaluate the Safety and Efficacy of Dibotatug (DR-01) in Adults With Bone Marrow Failure Syndromes
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07712562Natural History of Acquired and Inherited Bone Marrow Failure Syndromes
Nagre-recruitObservasyonal na pag-aaral
Edad 2 hanggang 99 · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT05012111Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis
Nagre-recruitPhase 2
Edad 4 hanggang 75 · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT03520647Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT01137643AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
Nagre-recruitPhase 2
1 Day – 30 Years · Lahat ng kasarian · Na-update Okt 23, 2026 · NCT04099966Haploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic Anemia
Nagre-recruitPhase 2
Edad 1 hanggang 75 · Lahat ng kasarian · Na-update Okt 14, 2026 · NCT02828592Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
Nagre-recruitMaagang Phase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06398457Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
Nagre-recruitPhase 1/2
Edad 4 hanggang 75 · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT03173937Haploidentical HCT for Severe Aplastic Anemia
Nagre-recruitPhase 2
Hanggang edad 21 · Lahat ng kasarian · Na-update Set 16, 2026 · NCT04558736The HOPE Biobank Resource (BMT CTN 2402 HOPE)
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Lahat ng edad · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT07227155A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT01351545TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
Nagre-recruitPhase 2
Edad 0 hanggang 21 · Lahat ng kasarian · Na-update Hul 1, 2026 · NCT04356469Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 22, 2026 · NCT01624805Let's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular Therapy
Nagre-recruit
Edad 8 pataas · Lahat ng kasarian · Na-update Hun 4, 2026 · NCT06689800MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.
Nagre-recruitPhase 2
Edad 0 hanggang 75 · Lahat ng kasarian · Na-update Hun 3, 2026 · NCT06412497Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)
Nagre-recruitPhase 2
Edad 3 hanggang 99 · Lahat ng kasarian · Na-update Mar 9, 2026 · NCT04304820Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia
Nagre-recruitPhase 2
Edad 3 hanggang 75 · Lahat ng kasarian · Na-update Peb 17, 2026 · NCT06517641Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders
Nagre-recruitPhase 2
Hanggang edad 65 · Lahat ng kasarian · Na-update Ene 30, 2026 · NCT03579875A Reduced-Intensity Conditioning Regimen (Cyclophosphamide, Pentostatin, Anti-thymocyte Globulin) Followed by Haploidentical Hematopoietic Stem Cell Transplant for the Treatment of Patients With Refractory or Recurrent Severe Aplastic Anemia
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Hanggang edad 75 · Lahat ng kasarian · Na-update Ene 5, 2026 · NCT05757310A Study of Emapalumab for Pediatric Aplastic Anemia
Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo
Edad 0 hanggang 25 · Lahat ng kasarian · Na-update Dis 17, 2025 · NCT06430788Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors
Nagre-recruitPhase 2
Edad 10 hanggang 30 · Lahat ng kasarian · Na-update Dis 4, 2025 · NCT05194397Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.